Genetic Susceptibility to IgA Nephropathy (Version 2.0)
Krzysztof Kiryluk, MD, MS and David A. Fasel
Use this calculator to determine an individual's risk of developing IgA nephropathy based on specific genetic markers. The risk score equation is based on the 15 SNPs associated with IgA nephropathy in the analysis of 20,612 individuals from 14 international case-control cohorts of European and Asian ancestry. The risk score is standardized using genotypes of 1,050 individuals from 52 worldwide populations included in the Human Genome Diversity Project (HGDP). This replaces the previous 7 SNP calculator.
To calculate the disease risk, select the genotypes from the drop-down menus:
Standardized risk score represents the number of standard deviations away from the worldwide mean. For each unit of standardized risk score, the risk of IgA nephropathy changes by 69.1%. Population average is based on the average risk score across 52 worldwide populations represented in the HGDP panel. Average risk is defined as less than one standard deviation from the worldwide mean.
Risk Score Equation:
Standardized Genetic Risk =
[ 0.16 × N(rs17019602:G) - 0.3 × N(rs6677604:A) - 0.22 × N(rs7763262:T) - 0.29 × N(rs9275224:A) + 0.48 × N(rs2856717:T) - 0.42 × N(rs9275596:C) - 0.17 × N(rs9357155:A) - 0.19 × N(rs1883414:T) - 0.06 × N(rs2738048:C) + 0.14 × N(rs10086568:A) + 0.18 × N(rs4077515:A) + 0.1 × N(rs11150612:A) - 0.24 × N(rs11574637:C) + 0.15 × N(rs3803800:A) + 0.17 × N(rs2412971:A) – Worldwide Mean ] / (Worldwide SD)
N = number of reference alleles for each SNP (0, 1, or 2 per individual genotype).
Worldwide Mean = -0.000548284 = mean risk score based on the HGDP data.
Worldwide SD = 0.01724761 = risk score standard deviation based on the HGDP data.
Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, Fasel D, Lata S, Prakash S, Shapiro S, Fischman C, Snyder HJ, Appel G, Izzi C, Viola BF, Dallera N, Del Vecchio L, Barlassina C, Salvi E, Bertinetto FE, Amoroso A, Savoldi S, Rocchietti M, Amore A, Peruzzi L, Coppo R, Salvadori M, Ravani P, Magistroni R, Ghiggeri GM, Caridi G, Bodria M, Lugani F, Allegri L, Delsante M, Maiorana M, Magnano A, Frasca G, Boer E, Boscutti G, Ponticelli C, Mignani R, Marcantoni C, Di Landro D, Santoro D, Pani A, Polci R, Feriozzi S, Chicca S, Galliani M, Gigante M, Gesualdo L, Zamboli P, Battaglia GG, Garozzo M, Maixnerová D, Tesar V, Eitner F, Rauen T, Floege J, Kovacs T, Nagy J, Mucha K, Pączek L, Zaniew M, Mizerska-Wasiak M, Roszkowska-Blaim M, Pawlaczyk K, Gale D, Barratt J, Thibaudin L, Berthoux F, Canaud G, Boland A, Metzger M, Panzer U, Suzuki H, Goto S, Narita I, Caliskan Y, Xie J, Hou P, Chen N, Zhang H, Wyatt RJ, Novak J, Julian BA, Feehally J, Stengel B, Cusi D, Lifton RP, Gharavi AG. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014 Oct 12. doi: 10.1038/ng.3118.
This tool is designed for individual risk prediction, however, it does not imply medical advice and it should not be used to guide clinical management until additional studies confirm its clinical utility. This risk assessment may not be applicable to all populations. Please refer to the original publication for detailed characteristics of the populations used for risk score discovery.
Last updated 10/2014